David Gionco
2014
In 2014, David Gionco earned a total compensation of $1.7M as Vice President of Finance and Chief Accounting Officer at Stemline Therapeutics, a 13,039% increase compared to previous year.
Compensation breakdown
| Bonus | $96,250 |
|---|---|
| Non-Equity Incentive Plan | $19,250 |
| Option Awards | $657,414 |
| Salary | $263,542 |
| Stock Awards | $654,600 |
| Other | $10,413 |
| Total | $1,701,469 |
Gionco received $657.4K in option awards, accounting for 39% of the total pay in 2014.
Gionco also received $96.3K in bonus, $19.3K in non-equity incentive plan, $263.5K in salary, $654.6K in stock awards and $10.4K in other compensation.
Rankings
In 2014, David Gionco's compensation ranked 5,221st out of 13,032 executives tracked by ExecPay. In other words, Gionco earned more than 59.9% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 5,221 out of 13,032 | 60th |
Division Manufacturing | 1,865 out of 4,966 | 62nd |
Major group Chemicals And Allied Products | 625 out of 1,686 | 63rd |
Industry group Drugs | 477 out of 1,365 | 65th |
Industry Pharmaceutical Preparations | 377 out of 1,043 | 64th |
Source: SEC filing on May 1, 2017.
Gionco's colleagues
We found three more compensation records of executives who worked with David Gionco at Stemline Therapeutics in 2014.